Tidal ETF Trust II YieldMax TSLA Option Income Strategy ETF (ARCA: TSLY)

Latest news for Tidal ETF Trust II YieldMax TSLA Option Income Strategy ETF (ARCA:TSLY)

The Fund is an actively managed exchange-traded fund (ETF) that seeks current income while maintaining the opportunity for exposure to the share price (i.e., the price returns) of the common stock of Tesla, Inc. (TSLA), subject to a limit on potential investment gains. The Fund will seek to employ its investment strategy as it relates to TSLA regardless of whether there are periods adverse market, economic, or other conditions and will not seek to take temporary defensive positions during such periods. As further described below, the Fund uses a synthetic covered call strategy to provide income and exposure to the share price returns of TSLA, subject to a limit on potential investment gains as a result of the nature of the options strategy it employs.

First American Government Obligations Fund

YieldMax TSLA Option Income Strategy ETF

Tidal ETF Trust II YieldMax TSLA Option Income Strategy ETF

N2OFF, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NITO#NASDAQ">NITO</a>) shares are trading higher premarket today. The clean-tech company has announced progress in its collaborative solar photovoltaic project in Melz, Germany, developed<a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/g42762810/n2off-inc-announces-its-jv-with-soltera-renewable-energy-ltd-obtained-an-approval-of-111-mwp-solar" rel="noreferrer noopener"> alongside </a><a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/g42762810/n2off-inc-announces-its-jv-with-soltera-renewable-energy-ltd-obtained-an-approval-of-111-mwp-solar" rel="noreferrer noopener">Solterra Renewable Energy Ltd.</a><a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/g42762810/n2off-inc-announces-its-jv-with-soltera-renewable-energy-ltd-obtained-an-approval-of-111-mwp-solar" rel="noreferrer noopener"></a>
On December 31, 2024, the Melz municipal committee approved the submission of the statutory plan for the 111 MWp solar PV facility after a thorough review of environmental and planning considerations.
The approval marks a critical step toward achieving ready-to-build status, which is expected by the end of 2025.
The Melz project is N2OFF&#8217;s first venture into the renewable energy sector aimed at fostering the development of high-potential renewable energy projects across Europe.
The Melz facility is a development within Solterra&#8217;s broader portfolio, with a total capacity of approximately 300 MW across Germany, Italy, and Poland.
&#8220;This achievement reflects the strength of our collaboration with Solterra and our shared vision of delivering impactful solutions that promote clean energy and environmental sustainability,&#8221; said David Palach, CEO of N2OFF.
As part of its collaboration with Solterra, N2OFF has provided financial support, including an installment of 470,000 euros as part of a 2 million euro loan commitment.
Price Action: NITO shares are trading higher by 84% at $0.4562 in premarket at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/42761825/ev-price-war-heats-up-as-chinese-automakers-extend-subsidies" target="_blank" rel="noreferrer noopener">EV Price War Heats Up As Chinese Automakers Extend Subsidies: Details</a></li>
</ul>
Photo via Shutterstock.

Equities

News

WIIM

Movers

NITO

Why Is Clean Tech Company N2OFF Stock Soaring Premarket Thursday?

Pure Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSTG#NYSE">PSTG</a>) has outperformed the market over the past 5 years by 15.57% on an annualized basis producing an average annual return of 28.24%. Currently, Pure Storage has a market capitalization of $20.31 billion. 
Buying $1000 In PSTG: If an investor had bought $1000 of PSTG stock 5 years ago, it would be worth $3,484.40 today based on a price of $62.26 for PSTG at the time of writing.
<h3>Pure Storage's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1735827308_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

PSTG

$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

Deutsche Bank analyst Scott Deuschle maintains Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) with a Buy and raises the price target from $184 to $215.

Price Target

Analyst Ratings

Deutsche Bank Maintains Buy on Boeing, Raises Price Target to $215

JP Morgan analyst Sebastiano Petti maintains BCE (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BCE#TSX">BCE</a>) with a Neutral and lowers the price target from C$41 to C$35.

TSX:BCE

JP Morgan Maintains Neutral on BCE, Lowers Price Target to C$35

The Department Of Government Efficiency (D.O.G.E.) meme coin is gaining steam, with traders predicting further upward movement ahead of the eponymous government agency launching under <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42035165/coinbase-ceo-brian-armstrong-says-doge-department-is-a-once-in-a-lifetime-opprtunity-advocates-abolishing-individual-income-tax">the Trump administration</a>.
What Happened: Crypto trader Unipcs highlighted a reversal playing out for the meme coin, potentially setting the stage for the next rally. D.O.G.E is up 48% over the past 24 hours, trading around a valuation of $140 million.
After reaching all-time highs, D.O.G.E underwent an 82% correction over six weeks—a pattern commonly observed in meme coins.
This sharp decline followed a parabolic 4,000% rally within a month, which itself came after a two-month phase of correction and consolidation. 
Over the last month, the D.O.G.E. meme coin dropped 48.7%, reflecting market volatility but also laying the groundwork for a potential rebound.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42640482/dogecoin-turns-green-as-trump-appoints-loyalist-katie-miller-to-the-department-of-government-efficiency">Dogecoin Turns Green As Trump Appoints Loyalist Katie Miller To The Department Of Government Efficiency</a>
What's Next: The Department of Government Efficiency is poised to play a key role in shaping Trump's administration policies, drawing public attention and fostering narratives around efficiency and reform.
Traders anticipate the launch event could act as a major driver for both the Department of Government Efficiency meme coin and Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>), fueling speculative momentum and increasing visibility for both coins. 
Dogecoin is up 6.6% over the past 24 hours.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42469967/elon-musk-vivek-ramaswamy-slam-sec-just-another-weaponized-institution">Elon Musk, Vivek Ramaswamy Slam SEC: &#8216;Just Another Weaponized Institution&#8217;</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

D.O.G.E. Zooms 48% Higher Ahead Of Elon Musk-Led Agency Launching In January: 'Ready For The Next Leg Up,' Millionaire Trader Vows

JP Morgan analyst Sebastiano Petti maintains TELUS (TSX:<a class="ticker" href="https://www.benzinga.com/stock/T#TSX">T</a>) with a Neutral and lowers the price target from C$23 to C$22.

TSX:T

JP Morgan Maintains Neutral on TELUS, Lowers Price Target to C$22

JP Morgan analyst Arun Jayaram maintains Halliburton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAL#NYSE">HAL</a>) with a Overweight and lowers the price target from $35 to $33.

JP Morgan Maintains Overweight on Halliburton, Lowers Price Target to $33

TSLA

Tesla shares are trading lower following Q4 production and delivery data.

Tesla Q4 Total Production 459,445, Deliveries 495,570

Deutsche Bank analyst Scott Deuschle upgrades RTX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) from Hold to Buy and raises the price target from $131 to $140.

Upgrades

Deutsche Bank Upgrades RTX to Buy, Raises Price Target to $140

Tech

MLGO

MicroAlgo Announces Development Of A Hybrid Classical-Quantum Algorithm

Deutsche Bank analyst Scott Deuschle downgrades TransDigm Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDG#NYSE">TDG</a>) from Buy to Hold and lowers the price target from $1444 to $1348.

Downgrades

Deutsche Bank Downgrades TransDigm Gr to Hold, Lowers Price Target to $1348

RDUS

Radius Pharmaceuticals Grants Pharmanovia Exclusive Commercialization Rights To Abaloparatide

General

LCID

SOUN

SoundHound AI And Lucid Announce Launch Of Lucid Assistant Voice Assistant

JP Morgan analyst Arun Jayaram maintains Schlumberger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) with a Overweight and lowers the price target from $55 to $48.

JP Morgan Maintains Overweight on Schlumberger, Lowers Price Target to $48

Management

AWRE

Aware Appoints David Traverse As Interim CEO

Warren Buffett is one of the richest men in the world, yet his down-to-earth lifestyle is almost as famous as his fortune. He still grabs <a href="https://www.benzinga.com/personal-finance/24/11/42025535/warren-buffett-has-a-mcgold-card-granting-him-a-lifetime-of-free-food-thats-why-the-buffett-family-has-christmas-dinner-at-mcdonalds">McDonald's for breakfast</a>, lives in the same modest Omaha home he bought in the 1950s and, despite his billions, has never been one to spoil his kids.&nbsp;
Instead, he raised Howard, Susan and Peter with a clear philosophy: <a href="https://www.benzinga.com/personal-finance/24/10/41198368/warren-buffetts-son-who-famously-cashed-in-his-90-000-inheritance-at-19-spends-millions-in-buffe">they wouldn't inherit the bulk of his wealth</a>, but they would learn to earn, save and appreciate the value of hard work.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
</ul>
One of the best examples of this? Howard Buffett's teenage dream of owning a Corvette. As a Forbes article from 1998 (A Son's Advice to His Father) recounted, Warren's unconventional parenting made a lasting impression, not just because of the car.
Howard, Warren's middle child, sat down for the interview in New York over Cokes and sandwiches, where he opened up about the unique challenges of growing up with a billionaire father. When he was 18 in 1973, he wanted one thing more than anything else: a brand-new Corvette. But Warren wasn't about to just write a check. Instead, he offered a deal.
Warren agreed to put $5,000 toward the car, but the money would count as Howard's birthday and Christmas presents for three years and his graduation gift. And Howard still had to come up with the remaining $2,500 himself. It was a classic Warren Buffett move – teaching his son that even a dream car came with a price.
See Also: The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a>
Howard took the deal and got his Corvette, but the lessons didn't stop there. Not long after, someone backed into the car. A bystander shrugged it off, saying, "No big deal! <a href="https://www.benzinga.com/personal-finance/24/03/37855579/warren-buffetts-daughter-says-they-lived-like-everybody-else-she-didnt-know-her-dad-was-rich-unt">That's the Buffett kid – </a>there's lots more where that came from." But Howard knew differently. He had to <a href="https://www.benzinga.com/personal-finance/24/09/40881429/warren-buffetts-daughter-asked-him-for-a-41-000-loan-to-remodel-her-kitchen-but-the-billionaire-">pay for the repairs</a> out of his pocket.
Finding his path outside his father's shadow wasn't easy. Like his siblings, Howard bounced between colleges before eventually dropping out. He spent time at Augustana College, Chapman College and the University of California at Irvine but never finished a degree. His journey eventually led him to politics, inspired by his grandfather, Howard Homan Buffett, a Republican congressman whom Warren greatly admired.
In 1988, Howard decided to run for commissioner of the Douglas County Board in Omaha. Before throwing his hat in the ring, he asked his dad whether losing an election would harm his reputation. Warren's response was encouraging and straightforward: "Not at all. People will respect you if you are willing to participate and put yourself on the line."
Trending: <a href="https://www.benzinga.com/money/advisor-adv-warren-buffett">Warren Buffett Flipped His Neighbor's $67,000 Life Savings Into A $50 Million Fortune — This Would Be Worth Over $500 Million Today</a>
However, Warren wasn't about to bankroll the campaign. In true Buffett fashion, he offered to match only 10% of the funds Howard could raise himself. "It was a good solution," Howard said, acknowledging that it pushed him to work harder.
The campaign wasn't without its challenges. At one community meeting in a lower-income neighborhood, Howard worried he'd be dismissed as just another rich kid from West Omaha. He turned to Warren for advice. "Just go down there, shake hands and be friendly," his dad told him. "They're all going to think you're going to be a jerk, so as long as you're not a jerk, you win."
As the interview ended, Howard reflected on his father's influence and their family dynamic. "Our family is close. No one is jockeying for position," he said, adding that Warren's advice and listening ear had been instrumental over the years. But Howard couldn't resist a parting quip about his dad's famously tight grip on money: "Now we'd love to have him loosen up a little!"
For Howard, the Corvette may have been the first deal he struck with his dad, but it certainly wasn't the last – and it left him with <a href="https://www.benzinga.com/money/are-you-rich">more than just a nice car</a>.
Read Next:
<ul>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
<li>The number of ‘401(k)' Millionaires is up 43% from last year —<a href="https://www.benzinga.com/money/401k-millionaires"> Here are three ways to join the club.</a></li>
</ul>

Personal Finance

Warren Buffett's Son Wanted A Corvette As A Teen – The Billionaire Gave Him $5,000 Towards It But Said No Other Gifts For 3 Years

Marsh & McLennan's Marsh McLennan Agency Acquires Acumen Solutions Group, Terms Not Disclosed

Across the recent three months, 10 analysts have shared their insights on SM Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SM#NYSE">SM</a>), expressing a variety of opinions spanning from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated SM Energy and provided 12-month price targets. The average target is $53.1, accompanied by a high estimate of $60.00 and a low estimate of $45.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 1.12%. 
<img src="https://www.benzinga.com/files/images/story/2025/1735826449_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The perception of SM Energy by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mike Scialla</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$57.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Hanwen Chang</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$45.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>William Janela</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$55.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Hanwen Chang</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$47.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Biju Perincheril</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$46.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Mike Scialla</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Overweight</td>
<td>$57.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Tim Rezvan</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$60.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Gabe Daoud</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Buy</td>
<td>$60.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Arun Jayaram</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$54.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Scott Hanold</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$50.00</td>
<td>$50.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to SM Energy. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of SM Energy compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of SM Energy's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into SM Energy's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/SM/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on SM Energy analyst ratings.</a>
<h2>Get to Know SM Energy Better</h2>
SM Energy Co is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and condensate, natural gas, and natural gas liquids. Operating primarily out of the United States, the company actively participates in joint ventures, prospects/leaseholds, and drill-to-earn opportunities. The majority of the company's revenue is derived from some of the United States' premier drilling locations. Drilling location interests have been traditionally obtained through oil and gas leases from third parties. SM Energy relies on its fleet of geologists, geophysicists, landmen, and engineers to help extract the full potential out of all properties held.
<h3>Financial Milestones: SM Energy's Journey</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining SM Energy's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 0.42% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Energy sector.
Net Margin: SM Energy's net margin is impressive, surpassing industry averages. With a net margin of 37.44%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 6.08%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): SM Energy's ROA stands out, surpassing industry averages. With an impressive ROA of 3.28%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: SM Energy's debt-to-equity ratio stands notably higher than the industry average, reaching 0.67. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>How Are Analyst Ratings Determined?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SM Energy Stock: A Deep Dive Into Analyst Perspectives (10 Ratings)

Across the recent three months, 11 analysts have shared their insights on Blueprint Medicines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPMC#NASDAQ">BPMC</a>), expressing a variety of opinions spanning from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $129.82, a high estimate of $151.00, and a low estimate of $88.00. A 3.76% drop is evident in the current average compared to the previous average price target of $134.89. 
<img src="https://www.benzinga.com/files/images/story/2025/1735826441_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
A clear picture of Blueprint Medicines's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Sudan Loganathan</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$140.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Reni Benjamin</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$125.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Reni Benjamin</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$125.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Andrew Fein</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$135.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Ami Fadia</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$135.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Brian Cheng</td>
<td>JP Morgan</td>
<td>Announces</td>
<td>Overweight</td>
<td>$126.00</td>
<td>-</td>
</tr>
<tr>
<td>Derek Archila</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$151.00</td>
<td>$153.00</td>
</tr>
<tr>
<td>Andrew Fein</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$135.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Ami Fadia</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$135.00</td>
<td>$133.00</td>
</tr>
<tr>
<td>Ami Fadia</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$133.00</td>
<td>$133.00</td>
</tr>
<tr>
<td>David Dai</td>
<td>UBS</td>
<td>Announces</td>
<td>Neutral</td>
<td>$88.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Blueprint Medicines. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Blueprint Medicines compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Blueprint Medicines's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
To gain a panoramic view of Blueprint Medicines's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/BPMC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Blueprint Medicines analyst ratings.</a>
<h2>About Blueprint Medicines</h2>
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
<h3>Key Indicators: Blueprint Medicines's Financial Health</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Blueprint Medicines displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 126.61%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.
Net Margin: Blueprint Medicines's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of -43.9%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Blueprint Medicines's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -17.77%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Blueprint Medicines's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -4.68%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Blueprint Medicines's debt-to-equity ratio surpasses industry norms, standing at 1.51. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Analyst Ratings: What Are They?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BPMC

What Analysts Are Saying About Blueprint Medicines Stock

TSLY: A Look At The Pros And Cons Of This Option Income ETF

The six Kurv single-stock covered call ETFs have lower distribution yields, but the stock price charts for the last four-plus months have very positive slopes.

Which Tesla ETF Delivers Unstoppable Returns?

Revisiting TSLY Now That Musk Is Potentially The Efficiency Czar (Upgrade)

YMAX: Is This 43% Dividend Yield Sustainable?

YieldMax TSLA Option Income Strategy ETF declares $1.22 dividend

YMAX: Unconventional Method To Wealth Building That Outperformed The S&P 500

TSLY: Strategy Has Proven To Be Effective

TSLY: Why It's Better Than Tesla Stock Right Now

The top 'Quant' momentum ETFs right now

YieldMax TSLA Option Income Strategy ETF declares $1.286 dividend

ARKQ

ARKX

BOIL

CONY

FBCG

FELG

FFOG

FNGG

GGLL

IETC

LSGR

MAGS

MSTY

NFLY

NUGO

NVDY

PYPY

QTUM

TSLL

TSLP

TSLR

TSLT

TSLY

ULTY

YMAG

YMAX

Press Releases

YieldMax™ Announces 1-for-2 Reverse Split of TSLY

Stock Split

YieldMax Announces 1-For-2 Reverse Split Of TSLY

Comments

Tidal ETF Trust II YieldMax TSLA Option Income Strategy ETF

News

Latest news for Tidal ETF Trust II YieldMax TSLA Option Income Strategy ETF (ARCA:TSLY)

Tuesday, February 13, 2024

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga